
Dicumarol
CAS No. 66-76-2
Dicumarol( NSC 17860 | NSC 41834 | NSC 221570 )
Catalog No. M15550 CAS No. 66-76-2
An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | 37 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDicumarol
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
-
DescriptionAn oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 17860 | NSC 41834 | NSC 221570
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorNQO1| PDK1
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number66-76-2
-
Formula Weight336.29
-
Molecular FormulaC19H12O6
-
Purity>98% (HPLC)
-
SolubilityEthanol: 67 mg/mL (199.23 mM); DMSO: 67 mg/mL (199.23 mM)
-
SMILESC1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O
-
Chemical Name4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jaiswal AK. Arch Biochem Biophys. 2000, 375(1):62-8.
molnova catalog



related products
-
AKR1C3-IN-4
AKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC 50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.
-
ML-090
ML-090 is NOX1-specific inhibitor(IC50 = 90 nM) which is >100 selectivity for NOX1 over NOX2, NOX3, NOX4 (all IC50s >10 μM).
-
APX-115 freebase
APX-115 (Ewha 18278)?is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively.